INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.890
+0.060 (3.28%)
At close: Oct 9, 2026, 4:00 PM EDT
1.895
+0.005 (0.26%)
After-hours: Oct 9, 2026, 7:30 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $52.45 million as of October 9, 2026. It is the 30,082nd most valuable company in the world and the 4,638th biggest in the United States. Its market cap has decreased by 1.84% in one year.
Market Cap
52.45M
Enterprise Value
35.45M
1-Year Change
-1.84%
Global Rank
Country Rank
#4,638 United States
Category
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $52.45M, a decrease of -32.60%. That is a compound annual growth rate of -5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 52.45M | 26.48% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clene | 55.15M |
| Hyperion DeFi | 55.01M |
| eXoZymes | 52.44M |
| ImageneBio | 52.22M |
| Annovis Bio | 51.98M |
| Edesa Biotech | 51.82M |
| Serina Therapeutics | 51.06M |
| CervoMed | 50.17M |